Pharmacotherapy of 'treatment resistant' type 2 diabetes.

about

Autophagy and its link to type II diabetes mellitus Pharmacological management of type 2 diabetes: what's new in 2017?Cardiovascular Effects of New Oral Glucose-Lowering Agents: DPP-4 and SGLT-2 Inhibitors.

P2860

Q33821526-ABDB4EF0-9CC0-4F16-BE7D-87BE497967DE Q47696671-384A5F8B-6618-4606-9372-3DB8885165C4 Q55053753-5F25FD3F-8090-4159-A786-A1414BD51B08

P2860

Pharmacotherapy of 'treatment resistant' type 2 diabetes.

Item

http://www.wikidata.org/entity/Q39170345

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pharmacotherapy of 'treatment resistant' type 2 diabetes.

@en

Pharmacotherapy of 'treatment resistant' type 2 diabetes.

@nl

type

Item

label

Pharmacotherapy of 'treatment resistant' type 2 diabetes.

@en

Pharmacotherapy of 'treatment resistant' type 2 diabetes.

@nl

prefLabel

Pharmacotherapy of 'treatment resistant' type 2 diabetes.

@en

Pharmacotherapy of 'treatment resistant' type 2 diabetes.

@nl

P1476

Pharmacotherapy of 'treatment resistant' type 2 diabetes.

@en

P2093

André J Scheen

http://www.w3.org/2001/XMLSchema#string

P2860

New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer

Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors

Strategies for Diabetes Management: Using Newer Oral Combination Therapies Early in the Disease

Practical combination therapy based on pathophysiology of type 2 diabetes

Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial

Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial

Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review.

Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.

Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study.

P304

503-515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14656566.2017.1297424

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28276972

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

pharmacotherapy

Pharmacotherapy of 'treatment resistant' type 2 diabetes.

about

P2860

P2860

Pharmacotherapy of 'treatment resistant' type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921